A specific gene variant, APOE2, appears to shield brain cells from damage and aging, potentially explaining why carriers live longer and face a lower risk of Alzheimer's disease. A new study suggests APOE2 helps neurons protect their DNA and resist senescence, a cellular aging process linked to neurodegeneration.
For years, scientists have recognized the protective advantage of carrying the APOE2 gene form but lacked a clear biological explanation. Research from the Buck Institute for Research on Aging, published in Aging Cell, indicates that APOE2 plays a role beyond its known function in cholesterol transport. The findings highlight how different versions of the APOE gene might influence the ability of brain cells to maintain and repair their genetic material over time.
"We've known for years that APOE2 carriers tend to live longer and have a lower risk of Alzheimer's, but the protective mechanism has been a black box," stated senior author Lisa M. Ellerby, PhD, professor at the Buck Institute. "Our work shows that APOE2 neurons are better at preventing and repairing DNA damage, and they resist the cellular aging program that drives so much of late-life decline. Our findings point to entirely new therapeutic directions."
The study compared the three common forms of the APOE gene: APOE2, APOE3, and APOE4. While differing by only two amino acids, these variants have significant impacts on brain aging. APOE4 is the leading genetic risk factor for late-onset Alzheimer's, whereas APOE2 is consistently associated with longer lifespans and reduced dementia risk in population studies. Researchers utilized human stem cells engineered to carry different APOE variants, differentiating them into two types of neurons. They also examined hippocampal tissue from mice genetically modified to express human APOE genes.
Results showed that neurons with the APOE2 variant accumulated less DNA damage. Gene sequencing revealed that APOE2 neurons actively engaged DNA repair pathways, while APOE4 neurons exhibited gene activity patterns linked to Alzheimer's. Direct measurements confirmed significantly less DNA damage in APOE2 neurons compared to those with APOE3 or APOE4.
Furthermore, APOE2 neurons demonstrated greater resistance to senescence, a state of irreversible cell cycle arrest associated with aging and disease. When exposed to stress, APOE2 neurons showed lower levels of senescence markers and maintained healthier internal structures. Interestingly, when APOE2 protein was added to APOE4 neurons, it reduced DNA damage, suggesting that some of its protective effects might be transferable.
These findings in human cells were mirrored in mouse brain tissue, where APOE2 mice exhibited characteristics of healthier brain cell aging. The study proposes a new perspective on APOE's role in brain aging, linking it directly to the maintenance of genomic integrity and resistance to cellular senescence, two critical factors in age-related decline and diseases like Alzheimer's.
